News & Events about Axogen Inc.
Ticker Report
7 months ago
StockNews.com upgraded shares of AxoGen (NASDAQ:AXGN Get Rating) from a hold rating to a buy rating in a report issued on Tuesday. Several other brokerages also recently weighed in on AXGN. JMP Securities reaffirmed a market outperform rating and set a $20.00 target price on shares of AxoGen...
JMP Securities reiterated their market outperform rating on shares of AxoGen (NASDAQ:AXGN Get Rating) in a research report sent to investors on Wednesday, Benzinga reports. JMP Securities currently has a $20.00 price objective on the medical equipment providers stock. Separately, StockNews.com ...
Globe Newswire
11 months ago
ALACHUA, Fla. and TAMPA, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited fourth quarter and full-year 2022 revenue. Preliminary ...
Globe Newswire
11 months ago
Study concluded allograft and autograft repairs delivered significantly better rates of meaningful sensory recovery in short gaps as compared to conduit repairs in a systematic meta-analysis including over 1,500 nerve repairs across 35 studiesALACHUA, Fla. and TAMPA, Fla., Jan. 05, 2023 (GLOBE ...
Globe Newswire
11 months ago
ALACHUA, Fla. and TAMPA, Fla., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Bri Majsiak, a Resensation patient, has been selected to ride on the 2023 Donate...